Skip to main navigation
About Us
Team
Programs and Pipeline
Menu Toggle
Summary and Pipeline
Orexin Receptor 2 Agonist Program
LockBody® Technology Platform
Investors
News
Careers
About Us
Team
Programs and Pipeline
Menu Toggle
Summary and Pipeline
Orexin Receptor 2 Agonist Program
LockBody® Technology Platform
Investors
News
Careers
Main Menu
About Us
Team
Programs and Pipeline
Menu Toggle
Summary and Pipeline
Orexin Receptor 2 Agonist Program
LockBody® Technology Platform
Investors
News
Careers
About Us
Team
Programs and Pipeline
Menu Toggle
Summary and Pipeline
Orexin Receptor 2 Agonist Program
LockBody® Technology Platform
Investors
News
Careers
About Us
Team
Programs and Pipeline
Menu Toggle
Summary and Pipeline
Orexin Receptor 2 Agonist Program
LockBody® Technology Platform
Investors
News
Careers
Main Menu
About Us
Team
Programs and Pipeline
Menu Toggle
Summary and Pipeline
Orexin Receptor 2 Agonist Program
LockBody® Technology Platform
Investors
News
Careers
Overview
Press Releases
Events & Publications
Events & Presentations
Publications
Financials
SEC Filings
Annual Reports
Stock Info
Stock Quote & Chart
Historical Price Lookup
Analyst Coverage
Governance
Documents & Charters
Management Team
Board of Directors
Committee Composition
Annual General Meeting
Shareholder Resources
FAQs
Email Alerts
Contact Us
RSS Feeds
PFIC Information
Annual Reports
March 28, 2024
2023 10-K
March 30, 2023
2022 10-K
March 30, 2022
2021 10-K
Print Page
FAQs
Email Alerts
Contact Us
RSS Feeds
